Sangmin Lee, MD, discusses a potential way to overcome resistance to venetoclax in acute myeloid leukemia.
Sangmin Lee, MD
Advertisement
Articles by Sangmin Lee, MD
Advertisement
Latest Updated Articles
Overcoming Resistance to Venetoclax in AMLPublished: March 4th 2019 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
4
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
5
